MIR7107: A Non-Coding RNA Molecule with Potential as a Drug Target or Biomarker
MIR7107: A Non-Coding RNA Molecule with Potential as a Drug Target or Biomarker
MIR7107 (hsa-miR-7107-3p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for several diseases, including cancer. The molecule is derived from the heat shock gene 7107 and has been shown to play a role in various cellular processes, including cell growth, apoptosis, and DNA damage repair.
Recent studies have suggested that MIR7107 may be a useful target for cancer treatment. For example, researchers have found that inhibiting the activity of MIR7107 can cause cells to undergo apoptosis, which can lead to a reduction in the size and number of tumors. Additionally, the molecule has been shown to be overexpressed in various types of cancer, which suggests that it may be a useful biomarker for these diseases.
Another potential application of MIR7107 is its potential as a therapeutic agent for neurodegenerative diseases. The molecule has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's and Parkinson's disease. By targeting MIR7107, researchers may be able to develop new treatments for these devastating conditions.
In addition to its potential as a drug target or biomarker, MIR7107 has also been shown to have potential as a diagnostic agent. The molecule has been shown to be expressed in a variety of tissues and cells, including brain, heart, and liver. This suggests that it may be a useful diagnostic tool for a range of conditions, including cancer, neurodegenerative diseases, and other inflammatory conditions.
Overall, MIR7107 is a promising molecule for drug development and research into the underlying mechanisms of various diseases. Further studies are needed to fully understand its potential as a drug target or biomarker, as well as its potential as a diagnostic agent.
Protein Name: MicroRNA 7107
The "MIR7107 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR7107 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG
